Amoxicillin/Clarithromycin

阿莫西林/克拉霉素

Report date: 2026/03/04 20:01:44

Base Information

Drug NameAmoxicillin/Clarithromycin

Drug Alias Name克拉霉素/阿莫西林Clarithromycin and Amoxicillin克拉霉素+阿莫西林Amoxicillin and ClarithromycinClarithromycin/Amoxicillin +[6]

ClassificationSmall molecules > Heterocyclic drugs > Antibiotics > β-lactam antibioticsSmall molecules > Heterocyclic drugs > Antibiotics > Macrolides antibiotics

Mechanisms of Action50S ribosomal subunit inhibitorsBacterial penicillin-binding protein inhibitors

Targets50S ribosomal subunitBacterial penicillin-binding protein

Therapy Area/IndicationsBacterial Infections

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryN/A

CombinationsYes Clarithromycin Amoxicillin

Global Highest StatusDiscontinued (Phase 2 Clinical)

Highest Status in ChinaN/A

Originator CompaniesAdvancis Pharmaceutical Corporation

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesAdvancis Pharmaceutical Corporation

Active IndicationsN/A

Inactive IndicationsBacterial Infections

Other Information

ATC CodeN/A